EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)—Part II: Incorporation and Stability of Butamben with Different Surfactants

Ananda P Matarazzo, Carlos A Rios, Gabriela Gerônimo, Roberta Ondei iD, Eneida de Paula iD, Márcia C Breitkreitz iD

Pharmaceutics · 27.06.2024 · 16 (7) · 863

DOI: 10.3390/pharmaceutics16070863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 27.06.2024. Verfasst von Ananda P Matarazzo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas 13083-871, SP, Brazil. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development, FAPESP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanostructured lipid carriers (NLCs) are typically composed of liquid lipids, solid lipids, and surfactants, enabling the encapsulation of lipophilic drugs. Butamben is a Class II anesthetic drug, according to the Biopharmaceutical Classification System (BCS); it has a log P of 2.87 and is considered a ‘brick dust’ (poorly water-soluble and poorly lipid-soluble) drug. This characteristic poses a challenge for the development of NLCs, as they are not soluble in the liquid lipid present in the NLC core. In a previous study, we developed an NLC core consisting of a solid lipid (CrodamolTM CP), a lipophilic liquid with medium polarity (SRTM Lauryl lactate), and a hydrophilic excipient (SRTM DMI) that allowed the solubilization of ‘brick dust’ types of drugs, including butamben. In this study, starting from the NLC core formulation previously developed we carried out an optimization of the surfactant system and evaluated their performance in aqueous medium. Three different surfactants (CrodasolTM HS HP, SynperonicTM PE/F68, and CroduretTM 40) were studied and, for each of them, a 23 factorial design was stablished, with total lipids, % surfactant, and sonication time (min) as the input variables and particle size (nm), polydispersity index (PDI), and zeta potential (mV) as the response variables. Stable NLCs were obtained using CrodasolTM HS HP and SynperonicTM PE/F68 as surfactants. Through a comparison between NLCs developed with and without SRTM DMI, it was observed that besides helping the solubilization of butamben in the NLC core, this excipient helped in stabilizing the system and decreasing particle size. NLCs containing CrodasolTM HS HP and SynperonicTM PE/F68 presented particle size values in the nanometric scale, PDI values lower than 0.3, and zeta potentials above |10|mV. Concerning NLCs’ stability, SBTB-NLC with SynperonicTM PE/F68 and butamben demonstrated stability over a 3-month period in aqueous medium. The remaining NLCs showed phase separation or precipitation during the 3-month analysis. Nevertheless, these formulations could be freeze-dried after preparation, which would avoid precipitation in an aqueous medium.

Schlagwörter

Stichwörter der Autor:innen

butambendesign of experimentnanostructured lipidic carriers

Autor:innen und Institutionen

  • Faculty of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas 13083-871, SP, Brazil.
  • Institute of Chemistry, University of Campinas (UNICAMP), Campinas 13083-862, SP, Brazil.
  • Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (Unicamp), Campinas 13083-862, SP, Brazil.
  • Croda Brazil, R. Croda, 580-Distrito Industrial, Campinas 13054-710, SP, Brazil.

ORCID-Profile: Roberta Ondei, Eneida de Paula, Márcia C Breitkreitz

Förderung

  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • National Council for Scientific and Technological Development
  • FAPESP
  • CAPES
  • CNPq/FAPESP
  • Croda

Zitieren

APA

Matarazzo, A. P., Rios, C. A., Gerônimo, G., Ondei, R., de Paula, E., & Breitkreitz, M. C. (2024). Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)—Part II: Incorporation and Stability of Butamben with Different Surfactants. Pharmaceutics, 16(7), 863. https://doi.org/10.3390/pharmaceutics16070863

Vancouver

Matarazzo AP, Rios CA, Gerônimo G, Ondei R, de Paula E, Breitkreitz MC. Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)—Part II: Incorporation and Stability of Butamben with Different Surfactants. Pharmaceutics. 2024;16(7):863. doi:10.3390/pharmaceutics16070863

BibTeX
@article{Matarazzo2024,
  author = {Matarazzo, Ananda P and Rios, Carlos A and Gerônimo, Gabriela and Ondei, Roberta and de Paula, Eneida and Breitkreitz, Márcia C},
  title = {Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)—Part II: Incorporation and Stability of Butamben with Different Surfactants},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {7},
  pages = {863},
  doi = {10.3390/pharmaceutics16070863}
}
Kostenlos starten →